Insider Selling: Shlomo Kramer Sells 40,000 Shares of Imperva Stock (IMPV)
Imperva (NASDAQ:IMPV) CEO Shlomo Kramer unloaded 40,000 shares of the stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $48.31, for a total value of $1,932,400.00. Following the completion of the sale, the chief executive officer now directly owns 1,219,521 shares of the company’s stock, valued at approximately $58,915,060. The sale was disclosed in a document filed with the SEC, which is available at this link.
Shares of Imperva (NASDAQ:IMPV) traded up 2.24% on Friday, hitting $49.69. 271,418 shares of the company’s stock traded hands. Imperva has a 52 week low of $31.39 and a 52 week high of $52.60. The stock has a 50-day moving average of $43.90 and a 200-day moving average of $44.73. The company’s market cap is $1.240 billion.
Imperva (NASDAQ:IMPV) last announced its earnings results on Tuesday, November 5th. The company reported ($0.01) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.05) by $0.04. The company had revenue of $35.10 million for the quarter, compared to the consensus estimate of $34.43 million. Imperva’s revenue was up 33.5% compared to the same quarter last year. On average, analysts predict that Imperva will post $-0.13 earnings per share for the current fiscal year.
A number of research firms have recently commented on IMPV. Analysts at Topeka Capital Markets initiated coverage on shares of Imperva in a research note to investors on Thursday, December 19th. They set a “hold” rating on the stock. Separately, analysts at BMO Capital Markets initiated coverage on shares of Imperva in a research note to investors on Thursday, December 19th. They set an “outperform” rating and a $52.00 price target on the stock. Finally, analysts at Barclays initiated coverage on shares of Imperva in a research note to investors on Thursday, November 21st. They set an “overweight” rating and a $55.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $50.33.
Imperva, Inc is a United States-based Company that develops data security solutions for business data in the data center.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.